Allworth Financial LP - HTG MOLECULAR DIAGNOSTICS IN ownership

HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of HTG MOLECULAR DIAGNOSTICS IN
ValueSharesWeighting
Q3 2022$2,000
-33.3%
3,3270.0%0.00%
Q2 2022$3,000
-40.0%
3,3270.0%0.00%
Q1 2022$5,000
-72.2%
3,3270.0%0.00%
Q4 2021$18,000
-5.3%
3,3270.0%0.00%
Q3 2021$19,0000.0%3,3270.0%0.00%
Q2 2021$19,000
+5.6%
3,3270.0%0.00%
Q1 2021$18,000
+12.5%
3,3270.0%0.00%
Q4 2020$16,0003,3270.00%
Other shareholders
HTG MOLECULAR DIAGNOSTICS IN shareholders Q3 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 6,966$7,0000.01%
TWO SIGMA SECURITIES, LLC 57,454$59,0000.00%
Virtu Financial LLC 13,127$14,0000.00%
UBS Group AG 26$00.00%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 60$00.00%
OSAIC HOLDINGS, INC. 13$00.00%
WELLS FARGO & COMPANY/MN 50$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 47,178$48,0000.00%
STATE STREET CORP 14,455$15,0000.00%
View complete list of HTG MOLECULAR DIAGNOSTICS IN shareholders